Evidence map›Paper›PMID 41519170›Full record

ArticleJournal of affective disorders2026

Widespread cortical thinning and subcortical alterations in mood and psychotic disorders across first-episode and chronic stages.

Shuqin Zhou, Akila Weerasekera, Chao Wang, Abigail Stein, Margaux Ameer, Virginie-Anne Chouinard, Ann Shinn, Kathryn E Lewandowski, Michael Murphy, Mark Halko and 3 more

Abstract read
In one paragraph

Article in Journal of affective disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shuqin ZhouPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA; McLean Imaging Center, McLean Hospital, Belmont, MA, 02478, USA; Harvard Medical School, Boston, MA, 02115, USA.
Akila WeerasekeraPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA; McLean Imaging Center, McLean Hospital, Belmont, MA, 02478, USA; Harvard Medical School, Boston, MA, 02115, USA.
Chao WangPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA; McLean Imaging Center, McLean Hospital, Belmont, MA, 02478, USA; Harvard Medical School, Boston, MA, 02115, USA.
Abigail SteinPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA.
Margaux AmeerPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA.
Virginie-Anne ChouinardPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA; Harvard Medical School, Boston, MA, 02115, USA.
Ann ShinnPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA; Harvard Medical School, Boston, MA, 02115, USA.
Kathryn E LewandowskiPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA; Harvard Medical School, Boston, MA, 02115, USA.
Michael MurphyPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA; Harvard Medical School, Boston, MA, 02115, USA.
Mark HalkoPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA; Harvard Medical School, Boston, MA, 02115, USA.
Halide Bilge TürközerPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA; Harvard Medical School, Boston, MA, 02115, USA.
Dost ÖngürPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA; Harvard Medical School, Boston, MA, 02115, USA.
Fei DuPsychotic Disorders Division, McLean Hospital, Belmont, MA, 02478, USA; McLean Imaging Center, McLean Hospital, Belmont, MA, 02478, USA; Harvard Medical School, Boston, MA, 02115, USA. Electronic address: fdu@mclean.harvard.edu.

Funding

Randomized controlled trial of enhanced coordinated specialty care (CSC 2.0)P50MH115846 · NIMH · MCLEAN HOSPITAL · PI MIGUEL HERNAN · 2019 to 2026
$16.9M
Early Life Stress and Depression: Molecular and Functional Imaging ApproachesR01MH095809 · NIMH · MCLEAN HOSPITAL · PI DU, FEI, PIZZAGALLI, DIEGO A · 2012 to 2024
$6.4M
Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's DementiaR01AG066670 · NIA · MCLEAN HOSPITAL · PI DU, FEI, FORESTER, BRENT PETER · 2020 to 2024
$4.0M
Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox BiologyR01MH135093 · NIMH · MCLEAN HOSPITAL · PI FEI DU, Dost Ongur · 2024 to 2026
$2.5M
Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early PsychosisR01MH114982 · NIMH · MCLEAN HOSPITAL · PI DU, FEI, ONGUR, DOST · 2019 to 2023
$2.4M
Excitation-inhibition imbalance, posteromedial cortical dysconnectivity, and thought disorder in first-episode psychosisK23MH118565 · NIMH · MCLEAN HOSPITAL · PI MURPHY, MICHAEL J · 2019 to 2023
$983k
NIA NIH HHS R01 AG066670NIMH NIH HHS K23 MH118565NIMH NIH HHS P50 MH115846NIMH NIH HHS R01 MH095809NIMH NIH HHS R01 MH114982NIMH NIH HHS R01 MH135093
6 · The paper itself

Abstract

Bipolar disorder (BP) and schizophrenia (SZ) share overlapping yet distinct structural brain alterations. Clarifying these differences is essential for improving diagnosis and prognosis. We hypothesized that cortical and subcortical alterations would differ between BP and SZ across illness stages and that these changes would relate to clinical severity. We examined cortical thickness and subcortical volumes using T1-weighted MRI in 438 participants recruited at McLean Hospital: 122 BP, 155 SZ, and 155 healthy controls (HC). Patient groups included both first-episode (FE-BP, FE-SZ) and chronic (CH-BP, CH-SZ) stages. BP patients demonstrated widespread cortical thinning, particularly in frontal, parietal, and temporal regions, with greater reductions in CH-BP. In CH-SZ, thinning was more circumscribed, affecting the precentral, superior frontal, and inferior parietal cortices. Subcortically, FE-BP showed corpus callosum (CC) volume loss, with further reductions in CH-BP, while CH-SZ exhibited central CC thinning. Ventricular enlargement was observed in CH-BP, FE-SZ, and CH-SZ, with marked left lateral ventricle expansion in CH-BP and CH-SZ. FE-BP also showed reduced caudate and amygdala volumes, with similar trends in chronic stages. Clinically, PANSS negative scores were consistently higher in SZ than BP, whereas positive symptoms did not differ. Cortical and subcortical alterations correlated with disease duration and PANSS scores, linking brain changes to symptom burden. BP exhibited larger morphometric effect sizes than SZ, despite greater negative symptom severity in SZ. This dissociation suggests that structural alterations do not necessarily parallel clinical severity, underscoring the importance of integrating neuroimaging and clinical measures to refine disease trajectories and diagnostic boundaries.

Indexed as

Bipolar DisorderCerebral CortexCerebral Cortical ThinningPsychotic DisordersSchizophreniaAdultAmygdalaChronic DiseaseCorpus CallosumFemaleHumansMagnetic Resonance ImagingMaleYoung AdultBipolar disorderBrain structureCorpus callosumSchizophreniaSubcortical volume

Identifiers

PMID41519170
PMCPMC12912282

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.